LIQUENT, EXTEDO And Lorenz Add Critical Publishing Capabilities To Industry's First Cloud-Based Application For Managing Submissions Content
"Veeva is applying technologies that will shape the future of application delivery," said Raoul Lorenz, Chief Executive Officer, LORENZ Life Sciences Group. "LORENZ is investing resources to understand further collaboration opportunities, as well as the applicability of Veeva technologies to our customer base."
LIQUENT, with more than 200 biopharmaceutical and life sciences clients worldwide, is a leading provider of software and professional services that support the regulatory business processes of global life sciences companies. Rick Riegel, Corporate Vice President of LIQUENT, a PAREXEL company, concluded, "Together with Veeva, we're providing an end-to-end solution for managing and publishing regulatory submissions in the cloud. When done right, cloud computing creates a true competitive advantage."
Also announced at DIA 2013 today, Veeva launched its cloud-based Vault Investigator Portal. Visit the company's booth # 1557 for demonstrations of Vault Submissions and the new LIQUENT integration as well as the company's new Vault Investigator Portal.
About Vault Development SuiteVeeva Vault Submissions is part of the Veeva Development Suite, the only cloud-based suite of integrated content management applications for the life sciences industry. Spanning every major part of a life sciences company - from R&D to clinical trials, to quality and manufacturing - the Veeva Development Suite gives pharmaceutical, biotechnology and medical device companies the ability to deploy a single content management system globally. All Development Suite applications offer real-time reporting and dashboards, an intuitive web interface, and a true multitenant cloud architecture that continuously delivers rapid innovation. About Veeva Systems Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence and customer success, Veeva has over 150 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a privately held company headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai and Tokyo. For more information, visit http://www.veeva.com. Copyright (c) 2013 Veeva Systems. All rights reserved. Veeva and the Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns other registered and unregistered trademarks. Other names used herein may be trademarks of their respective owners.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts